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Inﬂammatory bowel disease (IBD) arises from inappropriate ac-
tivation of themucosal immune system resulting in a state of chronic
inﬂammation with causal links to colon cancer. Helicobacter
hepaticus-infected Rag2−/− mice emulate many aspects of human
IBD, and our recent work using this experimental model highlights
the importance of neutrophils in the pathology of colitis. To deﬁne
molecular mechanisms linking colitis to the identity of disease bio-
markers, we performed a translational comparison of protein ex-
pression and protein damage products in tissues of mice and
human IBD patients. Analysis in inﬂamed mouse colons identiﬁed
the neutrophil- and macrophage-derived damage products 3-chlor-
otyrosine (Cl-Tyr) and 3-nitrotyrosine, both of which increased
with disease duration. Analysis also revealed higher Cl-Tyr levels
in colon relative to serum in patients with ulcerative colitis and
Crohn disease. The DNA chlorination damage product, 5-chloro-2′-
deoxycytidine, was quantiﬁed in diseased human colon samples
and found to be present at levels similar to those in inﬂamed
mouse colons. Multivariate analysis of these markers, together
with serum proteins and cytokines, revealed a general signature of
activated innate immunity in human IBD. Signatures in ulcerative
colitis sera were strongly suggestive of neutrophil activity, and
those in Crohn disease and mouse sera were suggestive of both
macrophage and neutrophil activity. These data point to innate
immunity as a major determinant of serum and tissue proﬁles
and provide insight into IBD disease processes.
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Inﬂammatory bowel disease (IBD) is a chronic and relapsingintestinal inﬂammatory disease that arises through unknown
genetic, environmental, and bacterial origins (1, 2). Ulcerative
colitis (UC) and Crohn disease (CD) are the two main forms
of IBD, and their incidence is increasing in industrialized countries
(3). Furthermore, IBD is a risk factor for the development of
colon cancer (4). Although the speciﬁc determinants remain elu-
sive, persistent inﬂammation is believed to play a signiﬁcant role
in colon cancer development (5).
Neutrophil recruitment and activation are key steps in the
intestinal innate immune response observed in IBD (6–8), and
studies with animal models of colitis highlight the relationship
between neutrophil inﬁltration and disease severity (9–11). We
recently reported results of a comprehensive analysis of histo-
pathology, changes in gene expression, and nucleic acid damage
occurring during progression of lower bowel disease in Rag2−/−
mice infected with Helicobacter hepaticus (Hh) (10). This mouse
model emulates many aspects of human IBD, and infected mice
develop severe colitis that progress into colon carcinoma, with
pronounced pathology in the cecum and proximal colon marked
by inﬁltration of neutrophils and macrophages (12, 13).
Phagocytes produce strong oxidants and radicals that damage
cellular macromolecules and promote tissue damage at sites of
inﬂammation (14–16). Myeloperoxidase (MPO) is an abun-
dant enzyme in neutrophils that produces hypochlorous acid
(HOCl) from hydrogen peroxide (H2O2) and chloride ion (17,
18). HOCl can oxidize and chlorinate DNA, proteins, and
lipids (19, 20). A prominent target of HOCl is tyrosine, which leads
to the formation of the stable aromatic residue, 3-chlorotyrosine
(Cl-Tyr) (21, 22). MPO also produces chlorinating species that
react with DNA to form chlorinated adducts such as 5-chloro-2′-
deoxycytidine (5-Cl-dC) (23), the presence of which was identiﬁed in
colon tissue of H. hepaticus-infected Rag2−/− mice (10). This modi-
ﬁcation of DNA may provide a mechanistic link between neu-
trophil activity and colitis-associated carcinoma (10, 24, 25).
Macrophages also contribute to the array of oxidants and
radicals at sites of inﬂammation through release of nitric oxide
(NO) generated by the inducible NO synthase (iNOS) enzyme.
NO reacts with superoxide anion (O2
−•) at diffusion-controlled
rates to yield highly reactive peroxynitrite (ONOO−) (26, 27).
MPO also reacts H2O2 with nitrite (NO2
−, the endpoint of cel-
lular NO oxidation) to produce the strong nitrating agent, ni-
trogen dioxide radical (NO2
•) (28). Both NO2
• and ONOO− can
react with tyrosine residues to generate the stable tyrosine ni-
tration product, 3-nitrotyrosine (Nitro-Tyr) (29, 30).
Multiple MS methods have been applied for determination of
Cl-Tyr and Nitro-Tyr levels in biological systems (10, 31–38), and
both have been detected in inﬂamed tissues from animals and
humans (11, 39). The presence of Nitro-Tyr has been demon-
strated in colon tissue of IBD patients by immunohistochemis-
try, and levels were reported to correlate with disease activity
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(40, 41). We undertook the present study to test the null hy-
pothesis that the H. hepaticus-infected mouse model of colitis
and colitis-associated carcinoma represents a useful surrogate of
human IBD. To examine this hypothesis, we ﬁrst quantiﬁed
levels of Nitro-Tyr and Cl-Tyr in proteins and 5-Cl-dC in DNA of
colon tissues of IBD patients. Comparison of these data with our
previous ﬁndings (10) further assessed the validity of this animal
model. We then tested the hypothesis that inﬂammation-induced
damage in the colon would be reﬂected in changes in serum
constituents, and would therefore serve as a noninvasive measure
of IBD activity. For this purpose, we determined levels of protein
chlorination and nitration products, acute-phase proteins, cyto-
kines, and chemokines in human and mouse sera. In addition,
gene expression of several inﬂammatory signaling molecules was
monitored in mice colons to determine whether colonic in-
ﬂammation was directly associated with serum cytokine levels.
We then used multivariate analysis to determine which systemic
inﬂammatory markers in serum were most closely associated
with disease activity and were also common to human IBD and
H. hepaticus-associated colitis in Rag2−/− mice.
Results
Evaluation of Chlorination Damage in Inﬂamed Human and Mice
Colons. We recently reported a comprehensive characterization
of nucleic acid damage products in the lower bowel of Rag2−/−
mice induced by chronic H. hepaticus infection (10). Chlorinated
adducts of DNA and RNA, which are generated from reaction
with MPO products, were associated with persistent inﬁltration
of neutrophils and macrophages at the site of inﬂammation.
Furthermore, these chlorination products increased in amount as
the inﬂammatory state lengthened. Importantly, inﬁltration by
these innate immune cells was accompanied by cancer initiation
and progression. Using the mouse as a model for colonic in-
ﬂammation, we tested the hypothesis that similar chlorination
events occurred during human IBD. MPO-derived chemical
damage to nucleic acids and proteins has not previously been
evaluated in colon tissues of IBD patients. Therefore, we
obtained colon biopsy tissue samples collected during resection
surgery to determine the abundance of chlorination products in
protein and DNA. We ﬁrst isolated DNA to quantify 5-Cl-dC for
analysis by LC-MS/MS (10, 42), which showed the presence of
5-Cl-dC at levels of 0.2–29.4 (mean ± SD 3.6 ± 6.3) adducts
per 108 nucleotides (Fig. 1). A similar range of 5-Cl-dC levels
was found in colons of H. hepaticus-infected mice (3.1–12.9
adducts per 108 nucleotides), although mean values in mice
were signiﬁcantly higher (5.5 ± 3.2 adducts 108 nucleotides) (Fig. 1)
(10). The similarity of adduct abundance in mouse and human
genomic DNA suggests a possible link between chlorination
damage to DNA and development of colitis-associated car-
cinoma in humans.
In addition to DNA, proteins are also major targets of cellular
damage associated with inﬂammation. MPO-derived products,
such as HOCl and NO2
•, react with tyrosine residues in proteins
to yield the stable chlorination and nitration products Cl-Tyr
and Nitro-Tyr, respectively. Previous studies suggest that Nitro-
Tyr is associated with human IBD severity (40, 41) and Cl-Tyr is
associated with colitis in mice (11). To examine the possible asso-
ciation of Cl-Tyr and Nitro-Tyr with disease activity, we quan-
tiﬁed their levels in colon biopsy samples from UC and CD
patients using stable isotope dilution LC-MS/MS analysis;
comparison of the two diseased tissues revealed no signiﬁcant
differences in levels of either Cl-Tyr or Nitro-Tyr (Fig. 2 A
and B). Mean values for Cl-Tyr and Nitro-Tyr in colon tissues
were 248 ± 266 and 54 ± 71 pg/mg protein, respectively. We
also assessed the possible association between 5-Cl-dC and Cl-
Tyr levels in the same tissue by Spearman correlation analysis
(ρ), but no signiﬁcant correlation was found (ρ = −0.18). This
result suggests that altered rates of adduct formation or repair
need to be considered when assessing macromolecular chlori-
nation damage products.
To evaluate the validity of the mouse as a model for chlori-
nation damage in human IBD, we measured Cl-Tyr and Nitro-
Tyr levels in colons from H. hepaticus-infected mice used in our
previous study (10). Analyses were carried out on tissues col-
lected from mice at 10 and 20 wk postinfection. In uninfected
control animals (n = 6 at 10 wk and n = 5 at 20 wk) Cl-Tyr was
not detectable (limit of detection of 2.8 pg/mg protein). How-
ever, tissues from infected animals contained Cl-Tyr at signiﬁ-
cantly elevated levels (P < 0.05 at 10 wk and P < 0.01 at 20 wk
postinfection) (Fig. 3A). The mean Cl-Tyr level in colons of
infected mice was 63.1 ± 53.3 pg/mg protein. In comparison with
human tissues, the mean level of Cl-Tyr in inﬂamed mice colons
was lower than the level determined in human IBD colon tissues
(Figs. 2 and 3).
Nitro-Tyr levels were also determined in mouse colon tissues.
In animals 20 wk postinfection (but not 10 wk postinfection),
Nitro-Tyr levels (31.3 ± 4.7 pg/mg protein) were signiﬁcantly
higher than in controls (Fig. 3B). Overall, the amounts of Nitro-
Tyr were lower than those of Cl-Tyr in colon tissues of both
human IBD patients and infected mice, indicating that protein
damage induced by nitration chemistry is less prevalent than that
caused by chlorination chemistry in vivo.
Evaluation of Cl-Tyr and Nitro-Tyr in Mouse and Human Serum. With
the objective of developing a noninvasive analytical platform
with the potential to accurately reﬂect cellular damage occurring
in colon tissue, we analyzed serum samples from IBD patients
for the presence of protein chlorination and nitration products.
To this end we quantiﬁed Cl-Tyr and Nitro-Tyr in serum proteins
from 57 UC patients, 62 CD patients, and 29 non-IBD controls
(Fig. 2 C and D). A portion of these UC and CD samples were
classiﬁed further as active disease (recurrence) and inactive
disease (remission) for the purpose of monitoring these protein
damage products as a function of disease activity. The levels of
Cl-Tyr were signiﬁcantly elevated in UC active sera (87.1 ± 63.6
pg/mg protein) relative to inactive (44.3 ± 55.1 pg/mg protein,
P value = 0.0003) and non-IBD controls (19.6 ± 20.8 pg/mg
protein, P value < 0.0001). Cl-Tyr levels in CD active sera (69.4 ±
51.5 pg/mg protein) were also elevated relative to CD inactive
sera (11.1 ± 8.2 pg/mg protein, P value < 0.0001) and non-IBD
controls (P value <0.0001). Quantitation of Nitro-Tyr in IBD
and non-IBD sera revealed only slight increase in the mean
values of UC active sera (29.8 ± 31.5 pg/mg protein) relative to
control (23.4 ± 26.6 pg/mg protein). A slight decrease in Nitro-
Tyr levels were recorded between UC inactive sera relative to
controls (14.7 ± 22.2 pg/mg protein, P value = 0.0309). Changes
Fig. 1. 5-Cl-dC was analyzed in human colon tissue derived from patients
with IBD and compared with previously determined levels in mice (UC,
n = 18; CD, n = 22, Rag2−/− H. hepaticus-infected mice, n = 12) (11). The 5-Cl-dC
levels in Rag2−/− H. hepaticus-infected mice were signiﬁcantly higher than
those observed in IBD colon tissues (P < 0.0002). Statistical signiﬁcance be-
tween groups was assessed by the Mann–Whitney U test and the line repre-
sents the mean value in each dataset.
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in Nitro-Tyr levels of CD active (16.7 ± 14.4 pg/mg protein) and
CD inactive (15.8 ± 24.9 pg/mg protein) were not statistically
different from control values.
Analysis of mouse serum revealed that infected animals at the
10-wk time point (n = 15) contained signiﬁcantly higher Cl-Tyr
levels than age-matched controls (128.9 ± 39.2 vs. 107.2 ±
84.8 pg/mg protein, respectively). By 20 wk, the Cl-Tyr serum
levels from H. hepaticus-infected animals declined to 74.1 ±
42.9 pg/mg protein. Nitro-Tyr levels were signiﬁcantly elevated
from control values at both 10 and 20 wk postinfection (Fig. 3 C
and D); infected animals were quantiﬁed at 34.5 ± 12.3 and
31.8 ± 2.9 pg/mg protein at 10 and 20 wk, respectively, and
age-matched controls exhibited Nitro-Tyr levels of 28.9 ± 0.1
and 29.6 ± 1.6 pg/mg protein at 10 and 20 wk, respectively.
A subset of these serum samples were collected from IBD pa-
tients at the time of resection surgery to make a direct comparison
between serum and colon tissue levels of Cl-Tyr and Nitro-Tyr.
Similarly, mouse sera were acquired at the time of colon tissue
collection. Spearman correlation analysis (ρ), revealed that neither
the modiﬁed tyrosine levels in human colon (Cl-Tyr ρ = 0.33,
Nitro-Tyr ρ = 0.30) nor those in mouse colon (Cl-Tyr ρ = −0.15,
Nitro-Tyr ρ = 0.07) correlated with their respective serum val-
ues. When human serum proteins were fractionated into sepa-
rate pools, 83% of Cl-Tyr was in the albumin fraction, about 2%
in the IgG fraction, and the remaining in other serum proteins.
Characterization of Serum Acute-Phase Proteins in Infected Mice and
Humans with IBD. We quantiﬁed serum acute-phase proteins in
humans and mice in an attempt to identify serum components
that may reﬂect disease pathogenesis and progression. We ﬁrst
performed a serum proteomics analysis to identify changes in the
abundance of serum proteins of UC active patients relative to
non-IBD controls. UC active (deﬁned by Simple Clinical Colitis
Activity Index as > 4) and non-IBD control samples were pooled
separately and processed for MS analysis. Peptides were labeled
with iTRAQ reagent for relative quantiﬁcation between group-
ings (43). The samples were separated by reverse-phase chro-
matography and analyzed by quadrupole time-of-ﬂight (QTOF)
MS. Seventy-seven serum proteins were identiﬁed: 16 proteins
increased and 9 proteins decreased in serum from UC patients
relative to controls (Table 1). The classic acute-phase pro-
teins, serum amyloid A (SAA, 11.7 -fold), α-1-antichymotrypsin
(SERPINA3, 4.2-fold), haptoglobin (2.6-fold), α-1-acid glyco-
protein (2.5-fold), and α-1-antitrypsin (SERPINA1) (2.3-fold)
showed the largest increases in abundance. Several proteins
decreased in abundance in serum including apolipoproteins A-I
and A-II and α-2-macroglobulin (A2M), which all decreased 0.5-
fold relative to non-IBD controls (Table 1 and Table S1).
Based on our serum proteomics results, we subsequently
measured acute-phase protein concentrations in individual UC
and CD serum samples. Using multiplex analysis, we quantiﬁed
SAA, ﬁbrinogen, A2M, serum amyloid P (SAP), procalcitonin,
ferritin, tissue plasminogen activator protein, and C-reactive
protein (CRP). Quantitation of human serum proteins from
individual samples identiﬁed increases in SAA (7.4-fold) and
ﬁbrinogen (1.4-fold) that were consistent with proteomics ﬁndings.
SAP showed an insigniﬁcant increase (1.3-fold) and A2M was un-
changed (Fig. 4 and Fig. S1). When a similar collection of proteins
was assayed in mouse serum, we observed signiﬁcant and infection-
related increases in the abundance of haptoglobin (300-fold),
SAP (7.8-fold), SAA3 (6.1-fold), α-1-acid glycoprotein (2.9-fold),
CRP (2.0-fold), and ﬁbrinogen (2.0-fold) (Fig. 4 and Fig. S1).
Serum Analysis of Cytokines and Chemokines. Levels of 27 cytokines
in human sera and 23 cytokines in mouse sera were measured to
identify inﬂammatory signals that may be reﬂective of disease
activity. In human UC sera, IL-8, G-CSF, IL-5, and eotaxin were
found to be signiﬁcantly increased, with a trend toward signiﬁcant
elevation for IP-10 (P < 0.06) (Fig. S2). No cytokines were
found to increase signiﬁcantly above control levels in CD sera,
although IL-8 trended toward signiﬁcance (P < 0.06). In mice,
several serum cytokines were signiﬁcantly elevated at 10 and 20
Fig. 2. Cl-Tyr and Nitro-Tyr were quantiﬁed in human tissues using stable
isotope dilution LC-MS/MS analysis. (A and B) Quantitation of Cl-Tyr and
Nitro-Tyr in IBD colon tissue (UC, n = 18; CD, n = 22). (C and D) Quantitation
of Cl-Tyr and Nitro-Tyr in IBD and non-IBD serum (Control, n = 29; UC active,
n = 38; UC inactive = 19; CD active, n = 42; CD inactive, n = 20). Cl-Tyr levels in
both active UC (P value < 0.0001) and active CD (P value < 0.0001) serum
samples were signiﬁcantly higher than those observed in non-IBD control
sera. Signiﬁcant elevation in Cl-Tyr levels were also observed between UC
active and UC inactive (P value = 0.0003), and CD active and CD inactive
(P value < 0.0001) samples. A signiﬁcant elevation was found in Nitro-Tyr
levels between UC active and UC inactive (P value = 0.0038) samples. Sta-
tistical analysis for all panels is presented as box-and-whisker plots show-
ing the median value (line), the interquartile range (box), and Tukey
whiskers deﬁning data within 1.5-fold of the interquartile range; all data
outside the whiskers are presented as individual data points. Statistical
signiﬁcance between groups (two groups) was assessed by the Mann–
Whitney U test.
Fig. 3. Analysis of modiﬁed tyrosine residues following 10 and 20 wk
postinfection with H. hepaticus or from sham-infected Rag2−/− mice. (A and
B) Cl-Tyr levels in Rag2−/−mouse colon signiﬁcantly increased at both 10 and
20 wk postinfection, and Nitro-Tyr levels in the Rag2−/−mouse colon signiﬁcantly
increased at 20 wk postinfection (10 wk +Hh or −Hh, n = 6; 20 wk +Hh or −Hh,
n = 5). (C and D) Cl-Tyr analysis in Rag2−/− mouse serum demonstrated a sig-
niﬁcant increase in chlorination damage at 10 wk and a signiﬁcant decrease
at 20 wk (*), and Nitro-Tyr levels in Rag2−/− mouse serum increased at both
10 and 20 wk postinfection (10 wk +Hh or −Hh, n = 12; 20 wk +Hh, n = 13;
20 wk −Hh, n = 11). Statistical analysis performed as described in Fig. 2.
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wk in response to infection (Table S1). A strong Th17-type
inﬂammatory response [IL-17, G-CSF, Kupffer cell (KC), and
IL-6] was observed in the serum of infected mice. Additionally,
IL-12(p35), IL-9, and IL-13 also displayed signiﬁcant serum
increases relative to age-matched controls.
Quantitative PCR Array-Based Transcript Proﬁling of Inﬂammatory
Stimuli in Mouse Colon. Colon tissues were collected from a sub-
set of mice for the purpose of monitoring the gene expression of
several inﬂammatory signaling molecules and to determine if
colonic inﬂammation was directly associated with serum cytokine
Table 1. Untargeted serum proteomic analysis in human UC: Up- and down-regulated proteins
Uniprot suggested name Fold-change (increase or decrease) UniProtKB %Coverage %Coverage(95%) Peptides(95%)
Increase
Serum Amyloid A 11.7 P02735 85.3 35.2 4
α-1-Antichymotrypsin (SERPINA3) 4.2 P01011 63.8 17.3 8
Haptoglobin 2.6 P00738 86.9 56.4 50
α-1-Acid glycoprotein 1 (Orosomucoid 1) 2.5 P02763 74.1 36.3 12
α-1-Antitrypsin (SERPINA1) 2.3 P01009 82.1 60.3 52
Leucine-rich α-2-glycoprotein 1.9 P02750 55.0 8.1 3
Peptidoglycan recognition protein 2 1.7 Q96PD5 35.1 2.4 1
Plasma protease C1 inhibitor (SERPING1) 1.5 P05155 53.0 14.2 10
β-2-glycoprotein 1 1.5 P02749 63.5 11.6 4
Hemopexin 1.4 P02790 58.9 25.1 15
α-1-Acid glycoprotein 2 (Orosomucoid 2) 1.3 P19652 74.6 22.4 6
Complement factor H 1.3 P08603 50.7 9.2 11
Vitronectin 1.3 P04004 54.4 13.0 7
Heparin cofactor 2 (SERPIND1) 1.3 P05546 50.9 8.8 5
Complement factor B 1.3 P04186 51.4 13.3 12
α-1B-glycoprotein 1.3 P04217 53.3 17.2 7
Decrease
Transferrin 0.7 P02787 87.4 63.7 93
Tissue-type plasminogen activator 0.7 P00750 46.8 10.4 7
α-2-HS-glycoprotein 0.7 P02765 49.9 20.4 5
Interα-trypsin inhibitor heavy chain H2 0.7 P19823 47.7 4.3 3
Retinol-binding protein 4 0.6 P02753 59.7 10.5 3
Hemoglobin subunit-β 0.6 P68871 87.1 43.5 6
Apolipoprotein A-II 0.5 P02652 80.0 41.0 10
Apolipoprotein A-I 0.5 P02647 94.0 69.7 46
α-2-Macroglobulin 0.5 P01023 76.5 47.7 90
Fig. 4. Acute-phase proteins were quantiﬁed in the serum of humans (A–E ) and mice (F–K ) by multiplex methodologies (Control, n = 29; UC, n = 20; CD,
n = 20; 10 wk +Hh, n = 10; 10 wk −Hh, n = 11; 20 wk +Hh, n = 13; 20 wk −Hh, n = 12). Results were considered signiﬁcant when P < 0.05. Statistical analysis
performed as described in Fig. 2.
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levels. Expression proﬁles were characterized in samples col-
lected at 10 and 20 wk postinfection from H. hepaticus-infected
and age-matched control mice. A distinct pattern of cytokine
gene expression was observed in colon relative to serum cytokine
protein levels (Fig. 5, Fig. S3, and Tables S2 and S3). In tissue,
the IL-17 and IL-22 pathways were robustly induced (GM-CSF,
IFN-γ, IL-6, IL-1β, KC, TNF-α). In the Rag2−/− mouse these
expression patterns point to phagocytes, innate lymphoid cells,
or epithelial cells as possible sources (44–47). Furthermore, the
signals strongly connect neutrophils to the site of inﬂammation,
conﬁrming the previous demonstration based on histological
evaluation (10). Neutrophil activation in the colon is also im-
plicated, based on inﬂammation-dependent accumulation of
Cl-Tyr in these tissues. An additional cytokine network observed
in the colon produced IL-12(p40), mitogen-activated protein
kinase (MIP)-1α, and MIP-1β. Release of these cytokines and
chemokines [particularly IL-12(p40)] in the colon also suggests
a role for monocytes, macrophages, and dendritic cells in the
pathogenesis of disease. Pronounced expression of IL-12(p40)
and RANTES coupled to the increased transcript levels of MIP-1β,
TNF-α, and IFN-γ suggest the possible activation of NK cells in
the colon, which may also contribute to tissue injury.
Multivariate Analysis of Serum Targets. We further analyzed sys-
temic inﬂammatory markers of IBD patients using multivariate
analysis to determine which serum features were most associated
with disease activity in vivo. IBD patients classiﬁed as having
clinically active disease were modeled against non-IBD controls.
UC disease activity was measured using the Simple Clinical
Colitis Activity Index (active deﬁned as > 4), and CD disease
activity was measured using the Harvey–Bradshaw Index (active
deﬁned as ≥ 5). In total, a collection of 35 serum targets (Cl-Tyr,
Nitro-Tyr, cytokines, and acute-phase proteins) from 69 patients
were subjected to multivariate analysis using partial least-squares
(discriminant analysis). To identify features that were most rel-
evant in classifying disease activity, the data were analyzed by
variable importance on the projection (VIP), which provides an
estimate of the discriminatory strength of a feature (a more
detailed description can be found in Materials and Methods). We
divided UC and CD into separate disease classes and modeled
each independently relative to non-IBD controls.
Partial least-squares analysis was more successful for UC
than CD. The results can be visually interpreted by inspection
of the 2D projections, and a quantitative assessment of the
model performance is reﬂected in the R2Y and Q2(cum) outputs
(assessments of the model ﬁt and the model prediction, respec-
tively). R2Y and Q2(cum) range from 0 to 1, with 0 indicating
poor performance and 1 indicating ideal performance. The UC
samples demonstrated good separation from the non-IBD con-
trols (Fig. 6), whereas the CD samples were not well-resolved
from the non-IBD controls (Fig. 7). This result is also reﬂected in
the model outputs, which produced R2Y = 0.87 and Q2(cum) =
0.82 for UC and R2Y = 0.55 and Q2(cum) = 0.15 for CD. The
UC model was then analyzed by VIP, which identiﬁed IL-8, Cl-
Tyr, SAA, CRP, procalcitonin, G-CSF, and tissue plasminogen
activator as the variables that were most inﬂuential for the
separation (VIP > 1.5). VIP analysis of the CD model iden-
tiﬁed procalcitonin, SAA, Nitro-Tyr, Cl-Tyr, and IP-10 as the
most inﬂuential variables for the separation (VIP > 1.5). These
top variables from the VIP analyses are therefore the most
predictive of disease activity in this model for UC and CD,
respectively.
We applied the same multivariate analysis to the H. hepaticus-
infected mice. Mouse sera were classiﬁed into two groups based
on H. hepaticus-infected (10 and 20 wk postinfection) and non-
infected controls (10 and 20 wk). In total, a collection of 30 se-
rum targets (cytokines and acute-phase proteins) from 33 mice
were analyzed and modeled using partial least-squares analysis.
The model outputs for the mouse analysis exceeded those at-
tained from the UC modeling and produced an R2Y = 0.93 and
Q2(cum) = 0.91 (Fig. 8). When VIP analysis was applied to the
model, haptoglobin, G-CSF, IL-12(p40), SAP, and α-1-acid gly-
coprotein were identiﬁed as the most inﬂuential variables on the
data separation indicating that they are predictive of colitis in
this model (Fig. 8).
Discussion
Determinants of inﬂammation-associated cancer development in
H. hepaticus-infected Rag2−/− mice were recently described (10).
The contributing factors to the onset of colon carcinoma were
inﬁltration of phagocytes and subsequent macromolecular damage
to DNA and RNA (principally chlorination) mediated by neu-
trophil activity. The present study was designed to quantify levels
of neutrophil-derived damage products in tissues of IBD patients
and in infected Rag2−/− mice tissues. Cl-Tyr and Nitro-Tyr were
quantiﬁed in human colon and serum from UC and CD patients,
and Cl-Tyr levels were found to be higher in colon than in serum.
In H. hepaticus-infected mice, both Cl-Tyr and Nitro-Tyr were
present and increased in amounts as the disease progressed over
time. Additionally, 5-Cl-dC was found to be present in colon
Fig. 5. qPCR analysis of cytokine and chemokine transcripts in H. hepaticus-infected Rag2−/− mouse colon. (A) Gene-expression data for cytokines and
chemokines in the Rag2−/− mouse colon at 10 and 20 wk postinfection. All inﬂammatory targets in this plot exhibited signiﬁcant changes (P < 0.05) at least
one time point (10 wk +Hh, n = 5; 10 wk −Hh, n = 5; 20 wk +Hh, n = 7; 20 wk −Hh, n = 5). A full list of the gene-expression data can be found in Table S3. Red
circles denote inﬂammatory targets that were up-regulated at both time points; green circles denote inﬂammatory targets that were down-regulated at both
time points; blue circles denote inﬂammatory targets that were differentially regulated. (B) Comparison of colon transcript levels and serum cytokine levels to
highlight common and compartment-speciﬁc changes.
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tissue of IBD patients at levels similar to those in colons of
H. hepaticus-infected mice. We also measured serum levels of
other protein products of inﬂammatory cells, including cytokines,
chemokines, and acute-phase proteins. A general signature of
activated innate immune response was observed in human sera;
the signature in sera from UC patients was strongly suggestive of
neutrophil activity, but that in sera of CD patients was suggestive
of macrophage and neutrophil activity. A similar spectrum of
serum inﬂammatory proteins was elevated in sera of infected
mice. Collectively, these data suggest that phagocytes contribute
to the development of IBD in both humans and infected mice,
and that Cl-Tyr may prove to be a useful marker of disease
activity in human IBD.
Chlorination Damage Products in Humans and Mice with IBD. Cl-Tyr
and Nitro-Tyr were quantiﬁed in 148 human serum samples
derived from IBD patients or non-IBD controls. A subset of the
IBD samples was paired with colon biopsy samples, which
allowed us to assess levels of chlorination and nitration damage
in inﬂamed tissues and compare them to systemic serum levels of
the same subjects. Forty paired samples were analyzed for Cl-Tyr
and Nitro-Tyr (22 from CD and 18 from UC); both adducts were
found to be present at higher average levels in colon tissue than
in serum. However, no clear correlation was observed between
serum and colon levels of either Nitro-Tyr or Cl-Tyr, suggesting
that these modiﬁed tyrosine residues in serum did not originate
from the colon. Because the liver is directly connected to the
intestine via the hepatic portal system, it is a likely ﬁrst target of
inﬂammatory factors arising in the colon. Thus, it is possible that
the increase in serum chlorination and nitration products may be
attributed at least partially to enhanced innate cell activity in the
liver following immune stimulation from the colon. In Citrobacter
rodentium-infected mice, liver inﬂammation can be observed 3 d
following colonic inﬂammation (48). In humans, the time course
required for inﬂammation in the colon to activation of the liver is
unknown. Primary sclerosing cholangitis is one of several liver
pathologies of signiﬁcant incidence in IBD patients (49), indi-
cating the importance of identifying extraintestinal factors that
may impact disease outcomes and potentially confound serum
proﬁles in IBD patients.
The association of these innate cell-mediated protein damage
products with IBD is noteworthy. Both Cl-Tyr and Nitro-Tyr are
stable, covalent modiﬁcations of tyrosine residues that form as
products of reactive chlorinating and nitrating species, respec-
tively (21, 29, 30). Prior studies of UC and CD investigated the
role of MPO in IBD development by immunohistochemical
staining or enzyme activity assays (16, 50). A limitation of such
studies is that analysis of MPO by immunohistochemistry pro-
vides information regarding MPO abundance, but not activity.
Activity assays require analysis of tissues in which activated
neutrophils are present (colon biopsy, fecal ﬂuid, and so forth).
Cl-Tyr represents a direct product of systemic MPO activity that
can be identiﬁed in a less-invasive manner in serum. When
Cl-Tyr levels were determined in UC and CD patients during
remission and active disease, the inactive samples appeared
more similar to non-IBD controls than to active disease patients.
The abundance of Cl-Tyr in the protein pool will be reﬂective of
the half-lives of the proteins in which the modiﬁcation is found.
In serum, the major chlorinated species is albumin, which is also
the most abundant serum protein, so the albumin signal in serum
is reﬂective of chlorination events amortized over the half-life of
albumin, which in humans is ∼20 d. Albumin is also synthesized
and released in the liver, further suggesting that the liver may
be a possible site for innate cell activation in IBD patients, and
therefore a possible source of the chlorination and nitration
products observed in serum.
We performed the same analyses of Cl-Tyr and Nitro-Tyr in
colon tissue and sera of Rag2−/− mice infected with H. hepaticus.
This well-deﬁned and highly reproducible model of IBD involves
a bacterial infection that induces chronic inﬂammation in the
lower bowel (12, 13). Furthermore, H. hepaticus is also associ-
ated with a clearly deﬁned liver pathology resulting in a predict-
able incidence of hepatitis in susceptible mice, including the
Rag2−/− strain (51–53). Cl-Tyr and Nitro-Tyr were found to in-
crease in colon tissue in a time- and disease-dependent manner
upon infection with H. hepaticus (Fig. 3). Cl-Tyr and Nitro-Tyr
levels in the colons of uninfected mice were near or below the
level of LC-MS/MS quantitation, but signiﬁcant increases in both
modiﬁcations were observed by 20 wk postinfection. These in-
creases were accompanied by a persistent mucosal inﬁltration of
neutrophils and macrophages over the course of infection (10).
Fig. 6. Multivariate modeling of UC serum analytes. Multivariate data analysis
of serum analytes using partial least squares analysis to identify discriminatory
features between UC patients (black squares, n = 20) and non-IBD controls
(green squares, n = 29). (A) A 2D projection of the partial least-squares
multivariate analysis, which produced separation of UC patients from non-
IBD controls. The model produced R2Y = 0.87 (model ﬁt) and Q2(cum) =
0.82 (model prediction). (B) List of the top VIPs (VIP > 1.0) in the dataset
that were most inﬂuential on the data separation.
Fig. 7. Multivariate modeling of CD serum analytes. Multivariate data
analysis of serum analytes to identify discriminatory features between CD pa-
tients (red squares, n = 20) and non-IBD controls (green squares, n = 29). (A) A
2D projection of the partial least-squares multivariate analysis, which shows
an overlapping distribution of CD patients and non-IBD controls. The model
produced R2Y = 0.55 (model ﬁt) and Q2(cum) = 0.15 (model prediction). (B)
List of the top VIPs (VIP > 1.0) in the dataset that were most inﬂuential on
the data separation.
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Previously, we reported an increase in chlorination damage to
nucleosides in mouse colon at 20 wk postinfection (10). Over the
same time course in the present study we observed the accumu-
lation of Cl-Tyr and Nitro-Tyr in proteins of mouse colon. Col-
lectively, these data suggest that chlorination damage products
(both to protein and nucleic acids) arising from neutrophil ac-
tivity at the site of inﬂammation increase over the course of
disease progression. We extended these observations into humans
to assess levels of 5-Cl-dC in colon samples from IBD patients.
The DNA damage product 5-Cl-dC was found to be present at
similar levels in human colon tissue and in inﬂamed colonic
tissues of mice. This represents a unique ﬁnding that associates
nucleoside chlorination damage products with inﬂammation in
colon tissue of IBD patients. Although the average values in
mouse colons were higher than those found in human tissues,
the range of data were overlapping (Fig. 1), which suggests that
5-Cl-dC may be a contributing factor in the initiation of colon
carcinogenesis through either mutational or gene silencing
mechanisms (54–56).
Serum Cytokine and Acute-Phase Protein Analysis. An array of
cytokines and acute-phase proteins was analyzed in the sera of
IBD patients and mice for the purpose of identifying differences
between control and diseased subjects. These serum factors were
then subjected to multivariate analysis (partial least-squares) to
identify important features discriminatory for disease activity.
The principal observation from the data analysis in IBD patients
was a systemic increase in factors associated with innate immune
cell recruitment and activation. Among the 27 cytokines mea-
sured in human serum, signiﬁcant changes were observed almost
exclusively in molecules that activate and recruit innate cells
(Fig. S2). Based on multivariate analysis of data from UC
patients, IL-8, G-CSF, and Cl-Tyr were all found to associate
with disease activity; these are strongly associated with neutro-
phil activation and recruitment. Multivariate analysis of CD pa-
tients showed Nitro-Tyr, Cl-Tyr, IP-10, and IL-8, neutrophil- and
macrophage-associated factors, to be discriminatory for disease
activity. In the Rag2−/− mouse, G-CSF was the main neutrophil-
associated factor identiﬁed in serum to be discriminatory for in-
fection status; IL-12(p40) was also a discriminating factor in
mouse serum and it is important for macrophage regulation.
Correspondingly, we observed modest increases in Nitro-Tyr
levels in mouse serum samples. The increase in macrophage
recruitment, activation, and activity markers is consistent with
prior observations on the role of iNOS in the development of
colon cancer in the Rag2−/− mouse (9) and their accumulation
in the inﬂamed colon (10).
In the Rag2−/− mouse, distinct but overlapping cytokine sig-
natures were identiﬁed in serum compared with gene transcript
levels observed in colon. Both compartments displayed an in-
crease in IL-17–associated cytokines, consistent with previous
studies of mouse models of colitis (45, 57). In the colon, although
we observed a strong increase in IL-12(p40) expression, there
was a notable lack of induction of IL-23 (assessed by p19 ex-
pression). IL-23 is considered to be a driver of intestinal pa-
thology in the Rag2−/− mouse (45, 58), so the absence of this
transcript is unexplained. However, several signals downstream
of IL-23 were present (IL-17A, IL-22), suggesting that this
pathway was indeed activated. It is possible that IL-1β may have
produced a similar response to that of IL-23 in these tissues (59).
Recent studies suggest that host genetic factors and alterations in
the microbiome impact the immune response in the gut (60, 61).
Furthermore, we cannot rule out the possibility of protein sta-
bility relative to transcript stability as a confounding factor in our
analysis (62).
Our study identiﬁed several acute-phase proteins that are
commonly associated with IBD (63–65). Proteolytic products
of these acute-phase proteins may also be useful in assessing
IBD activity (66). Two proteins of potential interest were iden-
tiﬁed from the proteomics study: orosomucoid 2 (α-1-acid
glycoprotein 2) and peptidylglycan recognition protein 2 (PGRP2,
also named N-acetylmuramoyl-L-alanine amidase). Association of
orosmucoid 2 with UC disease activity is not established, but it has
been associated with development of colorectal cancer (67).
PGRP2 is a serum protein that hydrolyses peptidoglycan and
transgenic knockouts of PGRP2 exhibit enhanced colitis in mu-
rine models of IBD (68); its role in human IBD is unknown.
Multivariate Models. The partial least-squares analysis demon-
strated that UC was more amenable to modeling than was CD.
The reasons for the poor model behavior for CD are unclear, but
two possibilities are likely. First, there are reports that the
Harvey–Bradshaw Index is not completely reﬂective of tissue
pathology. In a recent study of CD, more than one-third of
enrolled patients with moderate disease activity were found to
show no evidence of mucosal ulcerations during endoscopic
evaluation (69). We have relied on clinical indices of disease
activity, not endoscopy, and UC inﬂammatory activity may be
more accurately reﬂected in the Simple Clinical Colitis Ac-
tivity Index than the mucosal inﬂammation of CD as measured
by the Harvey–Bradshaw Index. Second, the disease hetero-
geneity of CD may contribute to multiple subpopulations that
may have subtle or signiﬁcant changes in the cytokine proﬁles.
As a corollary, the extent of disease involvement is not quantiﬁed
in any clinical index, but may be critical in explaining discordance
between clinical indices and serum markers (i.e., proctitis may
cause an increase in symptoms compared with inﬂammation in
a large segment of small bowel, which could be largely clinically
silent). When we restricted both CD and UC to smaller sub-
populations (disease location, medication, and so forth) no
signiﬁcant observations were made, which is likely because these
groupings represent a small sample size that lack predictive
power. Genetic variations in affected patients were not investi-
gated in this study.
Fig. 8. Multivariate data analysis of serum analytes to identify discrimi-
natory features between Rag2− /− H. hepaticus-infected mice and the un-
infected controls. All infected (10 wk +Hh, black squares, n = 8; 20 wk +Hh,
green squares, n = 10) and control mice (10 wk −Hh, red squares, n = 6; 20 wk
−Hh, blue squares, n = 9) were pooled into two separate groups in this
model. (A) A 2D projection of the partial least squares multivariate analysis,
which produced clear separation of infected mice and uninfected controls.
The model produced R2Y = 0.93 (model ﬁt) and Q2(cum) = 0.91 (model
prediction). (B) List of the top VIPs (VIP > 1.0) in the dataset that were most
inﬂuential on the data separation.
E2338 | www.pnas.org/cgi/doi/10.1073/pnas.1222669110 Knutson et al.
In all cases of disease modeling, the mouse models were more
predictive than the human models. In fact, when the data were
restricted to only the 20-wk time point, the best model was
attained (Fig. S4). The mouse model of H. hepaticus-induced
IBD provides several opportunities to control variables com-
pared with the human studies; minimization of these variables
likely contributed to the improved performance. All Rag2−/−
mice are genetically equivalent but in human populations, the
genetic heterogeneity may result in substantial variability. To
initiate colitis in the mouse, animals are infected with a mouse
pathogen, H. hepaticus. The initiating events that trigger IBD in
human populations probably vary within each disease, although a
response to a commensal or pathogenic bacterium is a likely initi-
ating event (70). The disease duration in the mouse was experi-
mentally controlled, whereas the human studies include differences
in the age of onset and the duration of the illness. Finally, in the
animal studies, there was no therapeutic intervention to alter the
immunological response, whereas in human studies patients were
frequently being treated with aggressive therapies, such as ste-
roids, TNF-α inhibitors, and other immunosuppressors to
attenuate disease symptoms.
Collectively, these data have evaluated the H. hepaticus-
infected Rag2−/− mouse as a model for human IBD. Strong
similarities were observed between the mouse and human
through the accumulation of nitration and chlorination damage
products in diseased colon tissue. In the mouse model of colitis,
these changes were dependent on disease severity and duration.
In human tissues, the serum accumulation of protein damage
products was signiﬁcantly increased over non-IBD controls. We
also report unique detection and quantiﬁcation of 5-Cl-dC in colon
tissue of IBD patients, and found its levels to fall within the same
range as those present in inﬂamed colons of H. hepaticus-infected
Rag2−/− mice. Inﬂammatory signals in mouse colons were indi-
cative of a Th17-type response, and were consistent with the
recruitment of neutrophils and macrophages to the site of in-
ﬂammation. The corresponding serum analysis suggested over-
lapping and distinct patterns that implicated both Th17-like and
innate cell activity. Human serum markers were strongly asso-
ciated with neutrophil factors in UC and both neutrophil and
macrophage factors in CD. The cytokine and modiﬁed tyrosine
targets in serum and tissue collectively support a role for the
innate immune system in IBD disease processes, which is also
reﬂected in the Rag2−/− H. hepaticus-induced colitis model.
Materials and Methods
Human Serum Sample Collection. Two cohorts of IBD samples were used in this
investigation. One cohort was obtained from the Cooperative Human Tissue
Network (Western Division at Vanderbilt University Medical Center), funded
by the National Cancer Institute, and all samples were obtained with in-
formed written consent and were anonymized before receipt at the Mas-
sachusetts Institute of Technology (MIT). Cooperative Human Tissue Network
patient cohort information is available in Table S4. All work performed at
Vanderbilt University was approved by the Vanderbilt University Insti-
tutional Review Board. These samples were comprised of colon biopsy
tissues paired to serum. A second cohort of serum samples was collected
by the Massachusetts General Hospital (MGH) Crohn’s and Colitis Center
with written informed consent obtained, and with approval by the MGH
Institutional Review Board. MGH patient cohort information is available
in Table S5. A set of non-IBD healthy control (n = 29) sera was also included
in this cohort. All work from these two sample cohorts was performed at
MIT with approval by the MIT Committee on the Use of Humans as Experi-
mental Subjects Committee.
Animal Husbandry, H. hepaticus Infection, and Tissue Collection. All experi-
ments were performed in accordance with the protocols approved by the
MIT Committee on Animal Care and with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals, as described previously (10).
Analysis of Chlorination and Nitration Damage Products. We analyzed 5-Cl-dC
as previously described (10, 42). Cl-Tyr and Nitro-Tyr in serum and colon
tissue were quantiﬁed by LC-MS/MS as previously described with mod-
iﬁcations (34, 36). Artifactual production of Cl-Tyr and Nitro-Tyr was mon-
itored during method development by addition of [13C6]-Tyr to tissue
samples; no artifactual formation was found. Serum or colon tissue samples
were thawed just before processing. Brieﬂy, colon tissue was homogenized
with lysis buffer (150 mM NaCl, 5 mM EDTA, 25 mM bicine, 0.5% CHAPS,
aprotinin, phenylmethylsulfonyl ﬂuoride, in 1x PBS), centrifuged, and the
supernatant was collected. Homogenized colon protein or serum (2 mg) was
spiked with internal standards (IS) (L-3-chloro-[13C9,
15N]-tyrosine and L-3-
nitro-[13C9,
15N]-tyrosine). The pronase E digestion was performed as previously
described (11) and followed by HPLC puriﬁcation. The collected HPLC frac-
tions were dried by SpeedVac before LC-MS analysis. All samples were an-
alyzed using Agilent 1200 Series stack (degasser, capillary pump, and
autosampler) and an Agilent 6430 triple quandrupole mass spectrometer.
Serum samples were applied to an Xbridge Phenyl column (3.5 μm, 1.0 ×
100 mm; Waters) and eluted isocratically with 25% methanol containing
0.1% formic acid. Cl-Tyr and IS were analyzed by multiple reaction moni-
toring (MRM) as follows: m/z 216→170 (Cl-Tyr) and m/z 226→179 (Cl-Tyr IS).
Nitro-Tyr and IS were analyzed by MRM with in-source fragmentation (MS3)
as follows: m/z 227→181→117 (Nitro-Tyr) and m/z 237→190→125 (Nitro-Tyr
IS). Because of inefﬁcient separation on the Phenyl column, colon samples
were applied to a Cogent Diamond Hydride column (4 μm, 2.1 × 150 mm;
Cogent) and eluted isocratically with 65% acetonitrile containing 0.1%
formic acid. Cl-Tyr and IS transitions were monitored as above. Nitro-Tyr and
IS were monitored by MRM as follows: m/z 227→181 (Nitro-Tyr) and m/z
190→125 (Nitro-Tyr IS). The Diamond Hydride column was washed with 50%
methanol containing 0.1% formic acid for 15 min after every three injections
to ensure optimum performance. Quantitation of Cl-Tyr and Nitro-Tyr was
based on six-point calibration curves (6.7–267 nM for Cl-Tyr and 8.7–267 nM
for Nitro-Tyr) in reference to the internal standard. All analyses were carried
out in triplicate. To identify the major serum proteins containing Cl-Tyr,
serum was fractionated into a pool containing albumin and IgG and pool
containing the remaining (depleted) proteins using Vivapure Anti-HAS/IgG
Kit (Sartorius-Stedim). Subsequently, the albumin was separated from the
IgG using a Protein G HP SpinTrap column (GE Healthcare). Each of these
fractions were analyzed separately as outlined above for the presence
of Cl-Tyr.
Serum Proteomics Analysis. Serum samples were ﬁrst depleted of albumin and
IgG using the Sartorius-Stedim Vivapure Anti-HSA/IgG Kit (Sartorius-Stedim)
as suggested by the manufacturer. UC samples were pooled into two sep-
arate, randomly selected fractions of 10 samples for both active disease and
inactive disease sera. Pooled samples were processed as outlined by the
manufacturer for 8-plex iTRAQ Reagent (ABSciex) labeling (43). Pooled
and labeled peptides were desalted by solid phase extraction (SPE) using
Strata-X, 60 mg, polymeric reversed phase resin (Phenomenex). SPE eluted
peptides were dried in a SpeedVac and redissolved in Offgel rehydration
buffer (Agilent Technologies), applied to a 24-well gel strip (pH 3–10; GE
Healthcare), and separated using an Offgel Fractionator as outlined by the
manufacturer (Agilent Technologies). Following separation, fractions were
removed and stored at −20 °C until LC-MS/MS analysis.
Sample injection and separation were performed using an Agilent 1100
series capillary pump and microwell plate autosampler, and an Agilent 1200
series nanopump, in line with a Cheminert 10 port dual, position nano-
volume, switching valve (Vici). Samples were applied to a custom-packed
capillary column (50-μm ID capillary tubing) using 5 μm, YMC ODS-AQ C18
resin (YMC-Gel). The following gradient was applied using the nanopump
(mobile phase A was 0.4% acetic acid in water, and mobile phase B was 0.4%
acetic acid in acetonitrile): isocratic hold of 2% B for 15 min, linear increase
from 2% B to 55% B over 60 min, linear increase to 95% B in 15 min, isocratic
hold at 95% B for 10 min, linear decrease to 2% B in 15 min, followed by an
isocratic hold for 30 min (re-equilibration). Peptide analysis was performed
using an AB Sciex QSTAR Elite QTOF MS equipped with a nanospray source
(Proxeon Biosystems) using an 8-μm silica PicoTip Emitter (New Objective).
The electrospray voltage was typically 1,300–1,500 V and applied at a con-
ductive union just downstream of the capillary column. Information-
dependent MS/MS analysis was performed on the four most abundant peaks
in each TOF-MS spectrum, which selected only multiply charged ions (+2 to +5).
The following instrument parameters were used: accumulation time 2 s,
total cycle time of 8.99 s, mass tolerance 50 ppm. Data were analyzed using
Spectrum Mill software (Agilent Technologies) for protein identiﬁcation,
and using Protein Pilot (Sciex) for protein identiﬁcation and relative quanti-
tation. Proteins were quantiﬁed by determining the ratio of the iTRAQ
marker ions for each combination of inactive and active samples, and then
averaging the response to determine fold-change.
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Multiplex Detection of Serum Cytokines, Chemokines, and Acute-Phase Proteins.
Human serumwas analyzed using the human 27-plex cytokine panel (Bio-Rad)
as speciﬁed by themanufacturer and contained the following targets: IL-1β, IL-
1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, Basic
FGF, Eotaxin, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF,
RANTES, TNF-α, and VEGF. Mouse serum was analyzed using the mouse 23-
plex cytokine panel (Bio-Rad) as speciﬁed by the manufacturer and contained
the following targets: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12
(p40), IL-12(p70), IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-
1α, MIP-1β, RANTES, and TNF-α. For human acute-phase protein analysis, se-
rum was analyzed using a human acute-phase panel (Bio-Rad) as speciﬁed by
the manufacturer and contained the following targets: A2M, CRP, ferritin,
ﬁbrinogen, haptoglobin, procalcitonin, SAA, SAP, and tissue plasminogen
activator. Mouse acute-phase proteins in serum were analyzed using the
separate platforms designed byMillipore as speciﬁed by the manufacturer and
contained the following targets: Fibrinogen, SAA3, adipsin, α-1-acid glyco-
protein, A2M, CRP, haptoglobin, and SAP. The following three human analytes
did not fall within the range of the standard curve for the majority of samples
and were excluded from further analysis: PDGF, RANTES, and haptoglobin.
Gene Expression. Analyses were performed using customized quantitative
PCR (qPCR) arrays (Qiagen) on an ABI 7900HT qPCR system (384-well block;
Life Technologies). All steps were performed according to the manufacturers’
instructions with the following speciﬁcations: RNA quality and quantity was
veriﬁed using a RNA 6000 Nano LabChip on an Agilent 2100 Bioanalyzer
(Agilent). RNA integrity numbers were consistently >7, indicating high-
quality RNA. Reverse transcription was performed with 400 ng of total RNA.
Genomic DNA and reverse transcription controls were included in each PCR
run to check for genomic DNA contaminations and impurities in RNA sam-
ples that may affect reverse transcription, respectively. All experiments met
quality control standards as recommended by the manufacturer. Ct values
were normalized to four different control genes (Actb, Gapdh, Hprt1, and
18SrRNA) for comparison of control and infected samples. Data were ana-
lyzed using the PCR Array Data Analysis Web Portal (www.sabiosciences.
com/pcrarraydataanalysis.php) according to the ΔΔCt method.
Multivariate and Statistical Data Analysis. All multivariate analysis was carried
out using SIMCA-P+ v11.5 software (Umetrics). The data were log10-trans-
formed before multivariate analysis. Disease classiﬁcation was assessed
clinically and used as the discriminant variable (dependent, Y-variable) in the
partial least-squares discriminant analysis. Serum analytes were used as the
independent variable (X-variable). Assessment of the model was carried out
by inspecting the R2Y and Q2(cum), which are outputs that describe the
model’s performance. R2Y is the fraction of the total Y variation that can be
explained by the model (model ﬁt), and Q2(cum) is the total variation of Y
that can be predicted by the model (model prediction). An R2Y or Q2(cum) of
1.0 indicates an ideal model ﬁt and a 100% relationship between all X and Y
variables. VIP analysis was used to estimate the importance that a particular
variable has on the classiﬁcation accuracy. The average VIP equals 1;
therefore, VIPs >1 provide greater predictive value than VIPs <1. A VIP value
signiﬁcantly less than 1 indicates that the feature is not predictive. All sta-
tistical analyses were performed using GraphPad Prism software, v6.0a for
Mac (GraphPad Software). Statistical signiﬁcance in serum targets between
patients groups (two groups) were assessed by the Mann–Whitney U test;
P values < 0.05 were considered signiﬁcant. The nonparametric Spearman’s
rank correlation coefﬁcient (ρ) was determined to identify if statistical de-
pendence existed between measured variables.
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